Skip to main content

Advertisement

Log in

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

A Correction to this article was published on 23 June 2020

This article has been updated

Abstract

Purpose

Patients with primary immunodeficiency (PID) are at risk of serious complications. However, data on the incidence and causes of emergency hospital admissions are scarce. The primary objective of the present study was to describe emergency hospital admissions among patients with PID, with a view to identifying “at-risk” patient profiles.

Methods

We performed a prospective observational 12-month multicenter study in France via the CEREDIH network of regional PID reference centers from November 2010 to October 2011. All patients with PIDs requiring emergency hospital admission were included.

Results

A total of 200 admissions concerned 137 patients (73 adults and 64 children, 53% of whom had antibody deficiencies). Thirty admissions were reported for 16 hematopoietic stem cell transplantation recipients. When considering the 170 admissions of non-transplant patients, 149 (85%) were related to acute infections (respiratory tract infections and gastrointestinal tract infections in 72 (36%) and 34 (17%) of cases, respectively). Seventy-seven percent of the admissions occurred during winter or spring (December to May). The in-hospital mortality rate was 8.8% (12 patients); death was related to a severe infection in 11 cases (8%) and Epstein-Barr virus–induced lymphoma in 1 case. Patients with a central venous catheter (n = 19, 13.9%) were significantly more hospitalized for an infection (94.7%) than for a non-infectious reason (5.3%) (p = 0.04).

Conclusion

Our data showed that the annual incidence of emergency hospital admission among patients with PID is 3.4%. The leading cause of emergency hospital admission was an acute infection, and having a central venous catheter was associated with a significantly greater risk of admission for an infectious episode.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Change history

  • 23 June 2020

    The original version of the article contained error regarding the presentation of the institutional authors in the PDF and html versions.

Abbreviations

CEREDIH:

Centre de Référence des Déficits Immunitaires Héréditaires

CGD:

Chronic granulomatous disease

CNS:

Central nervous system

COPD:

Chronic obstructive pulmonary disease

EBV:

Epstein-Barr virus

HRQoL:

Health-related quality of life

HSCT:

Hematopoietic stem cell transplantation

HSV:

Herpes simplex virus

NS:

Non-significant

PID:

Primary immunodeficiency

RSV:

Respiratory syncytial virus

References

  1. Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010 Oct;138(4):944–9.

    Article  Google Scholar 

  2. Unterman S, Zimmerman M, Tyo C, Sterk E, Gehm L, Edison M, et al. A descriptive analysis of 1251 solid organ transplant visits to the emergency department. West J Emerg Med. 2009 Feb;10(1):48–54.

    PubMed  PubMed Central  Google Scholar 

  3. Abbott KC, Hypolite I, Poropatich RK, Hshieh P, Cruess D, Hawkes CA, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis Off J Transplant Soc. 2001 Dec;3(4):203–11.

    Article  CAS  Google Scholar 

  4. Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth. 2012 Mar;108(3):452–9.

    Article  CAS  Google Scholar 

  5. Venkat A, Piontkowsky DM, Cooney RR, Srivastava AK, Suares GA, Heidelberger CP. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy. Ann Emerg Med. 2008 Sep;52(3):274–85.

    Article  Google Scholar 

  6. CEREDIH. The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol Orlando Fla. 2010 May;135(2):264–72.

    Article  Google Scholar 

  7. Center for Disease Control. CDC/NHSN surveillance definitions for specific types of infections. 2016.

  8. R Core Team. R: a language and environment for statistical computing [internet]. Vienna, Austria: R Foundation for Statistical Computing; 2015. Available from: https://www.R-project.org/

  9. Soler JJ, Sanchez L, Roman P, Martinez MA, Perpina M. Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. Respir Med. 2004 Apr;98(4):318–29.

    Article  Google Scholar 

  10. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med. 2005 Jun 13;165(11):1274–9.

    Article  Google Scholar 

  11. Billings J, Dixon J, Mijanovich T, Wennberg D. Case finding for patients at risk of readmission to hospital: development of algorithm to identify high risk patients. BMJ. 2006 Aug 12;333(7563):327.

    Article  Google Scholar 

  12. Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997 Sep;100(3):415–23.

    Article  CAS  Google Scholar 

  13. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84(1):16–22.

    Article  Google Scholar 

  14. Eades-Perner A-M, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007 Feb;147(2):306–12.

    Article  Google Scholar 

  15. Edgar JDM, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The United Kingdom Primary Immune Deficiency (UKPID) registry: report of the first 4 years’ activity 2008-2012. Clin Exp Immunol. 2014 Jan;175(1):68–78.

    Article  CAS  Google Scholar 

  16. Hutchinson AF, Graco M, Rasekaba TM, Parikh S, Berlowitz DJ, Lim WK. Relationship between health-related quality of life, comorbidities and acute health care utilisation, in adults with chronic conditions. Health Qual Life Outcomes. 2015;13:69.

    Article  Google Scholar 

  17. Barlogis V, Mahlaoui N, Auquier P, Pellier I, Fouyssac F, Vercasson C, et al. Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: a French reference center for PIDs (CEREDIH) study. J Allergy Clin Immunol. 2017 Apr;139(4):1275–1281.e7.

    Article  Google Scholar 

Download references

Acknowledgments

The European Society for Immunodeficiencies online database was used to collect the study data. The members of the CEREDIH French PID study group are (in alphabetical order) Laurent Aaron+, Daniel Adoue, Claire Aguilar, Nathalie Aladjidi, Alexandre Alcais, Zahir Amoura, Philippe Arlet, Corinne Armari-Alla, Brigitte Bader-Meunier, Sophie Bayart, Yves Bertrand, Boris Bienvenu, Stéphane Blanche, Damien Bodet, Bernard Bonnotte, Raphaël Borie, Patrick Boutard, Claire Briandet, Jean-Paul Brion, Jacques Brouard, Sarah Cohen-Beaussant, Laurence Costes, Louis-Jean Couderc, Pierre Cougoul, Virginie Courteille, Geneviève de Saint Basile, Catherine Devoldere, Anne Deville, Jean Donadieu, Eric Dore, Fabienne Dulieu, Christine Edan, Natacha Entz-Werle, Claire Fieschi, Amandine Forestier, Fanny Fouyssac, Vincent Gajdos, Lionel Galicier, Virginie Gandemer, Martine Gardembas, Catherine Gaud, Gaelle Guillerm, Eric Hachulla, Mohamed Hamidou, Olivier Hermine, Cyrille Hoarau, Sébastien Humbert, Arnaud Jaccard, Serge Jacquot, Jean-Philippe Jais, Roland Jaussaud, Pierre-Yves Jeandel, Kamila Kebaili, Anne-Sophie Korganow, Olivier Lambotte, Fanny Lanternier, Claire Larroche, Anne-Sophie Lascaux, Emmanuelle Le Moigne, Vincent Le Moing, Yvon Lebranchu, Marc Lecuit, Guillaume Lefevre, Richard Lemal, Valérie Li Thiao Te, Aude Marie-Cardine, Nicolas Martin Silva, Agathe Masseau, Christian Massot, Françoise Mazingue, Etienne Merlin, Gérard Michel, Frédéric Millot, Béatrice Monlibert, Fabrice Monpoux, Despina Moshous, Luc Mouthon, Martine Munzer, Bénédicte Neven, Raphaëlle Nove-Josserand, Eric Oksenhendler, Marie Ouachée-Chardin, Caroline Oudot, Anne Pagnier, Jean-Louis Pasquali, Marlène Pasquet, Yves Perel, Capucine Picard, Christophe Piguet, Dominique Plantaz, Johan Provot, Pierre Quartier, Frédéric Rieux-Laucat, Pascal Roblot, Pierre-Marie Roger, Pierre-Simon Rohrlich, Hervé Rubie, Valéry Salle, Françoise Sarrot-Reynauld, Amélie Servettaz, Jean-Louis Stephan, Nicolas Schleinitz, Felipe Suarez, Laure Swiader, Sophie Taque, Caroline Thomas, Olivier Tournilhac, Caroline Thumerelle, François Tron, Jean-Pierre Vannier, Jean-François Viallard.

Funding

The CEREDIH is funded by the French Ministry of Health. It has received additional, unrestricted educational grants from companies (LFB, GSK, Pfizer, CSL Behring, Shire, Octapharma, and Binding Site) and patient associations (AT-Europe and Trophée Guillaume).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Olivier Lortholary.

Ethics declarations

Patients newly included in the CEREDIH/ESID database gave their consent to participation; patients who were already registered in the database had given their consent previously. The study’s objectives and procedures were approved by the local investigation review board (CPP Ile de France II, Paris, France) on June 7, 2010.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 39 kb)

ESM 2

(DOCX 42 kb)

ESM 3

(DOCX 48 kb)

ESM 4

(DOCX 42 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coignard-Biehler, H., Mahlaoui, N., Pilmis, B. et al. A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency. J Clin Immunol 39, 702–712 (2019). https://doi.org/10.1007/s10875-019-00658-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-019-00658-9

Keywords

Navigation